IFNG and diffuse large B-cell lymphoma: Notably, in our study, patient samples from patients with FL who responded to therapy across all of the arms of the study exhibited a slightly higher IFN‐γ signature score than nonresponders (p = .02), while patients with DLBCL trended in the same direction (p = .08; Figure 5).